Redsense Medical AB (publ) (NGM:REDS)
Sweden
· Delayed Price · Currency is SEK 5.80
-0.10 (-1.69%)
At close: May 14, 2025
Redsense Medical AB Revenue
In the year 2024, Redsense Medical AB had annual revenue of 28.77M SEK with 12.74% growth. Redsense Medical AB had revenue of 12.69M in the quarter ending December 31, 2024, with 55.97% growth.
Revenue
28.77M
Revenue Growth
+12.74%
P/S Ratio
3.32
Revenue / Employee
5.75M
Employees
5
Market Cap
95.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28.77M | 3.25M | 12.74% |
| Dec 31, 2023 | 25.52M | 8.76M | 52.32% |
| Dec 31, 2022 | 16.75M | 410.00K | 2.51% |
| Dec 31, 2021 | 16.34M | -757.98K | -4.43% |
| Dec 31, 2020 | 17.10M | 2.87M | 20.19% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Medicover AB | 23.56B |
| Camurus AB | 1.87B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Elekta AB | 17.88B |